Prasugrel

CHEMBL1201772 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

373.4 g/mol

LogP

3.6

Phase

4

A blood-thinning medication used to prevent heart attacks and strokes in people who have had a heart attack or severe chest pain and were treated with a procedure to open blocked coronary arteries. It works by preventing blood platelets from clumping together to form dangerous clots.

Masse moléculaire

373,4000 g/mol

LogP

3,60

TPSA

74,90 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Cardiovascular Disease Asthma Migraine Systemic Lupus Erythematosus Chronic Kidney Disease Stroke Deep Vein Thrombosis / Pulmonary Embolism Type 2 Diabetes Gout HIV/AIDS Heart Failure Atrial Fibrillation

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2

InChI

InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3

Molecular Formula

C20H20FNO3S

HBD / HBA

- / 6

Liaisons Rotatives

6

Atomes Lourds

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A blood-thinning medication used to prevent heart attacks and strokes in people who have had a heart attack or severe chest pain and were treated with a procedure to open blocked coronary arteries. It works by preventing blood platelets from clumping together to form dangerous clots.

Yes, Prasugrel is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201772. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 6918456. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Prasugrel sur PillFYI

Structure

Données Clés

Formule: C20H20FNO3S
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.